Premium
Ligand Accessibility Insights to the Dengue Virus NS3‐NS2B Protease Assessed by Long‐Timescale Molecular Dynamics Simulations
Author(s) -
Kronenberger Thales,
Sá Magalhães Serafim Mateus,
Kumar Tonduru Arun,
Gonçalves Maltarollo Vinícius,
Poso Antti
Publication year - 2021
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.202100246
Subject(s) - ns3 , dengue virus , druggability , dengue fever , protease , virology , drug discovery , molecular dynamics , computational biology , biology , chemistry , enzyme , biochemistry , computational chemistry , gene
Dengue is a tropical disease caused by the dengue virus (DENV), with an estimate of 300 million new cases every year. Due to the limited vaccine efficiency and absence of effective antiviral treatment, new drug candidates are urgently needed. DENV NS3‐NS2B protease complex is essential for viral post‐translational processing and maturation, and this enzyme has been extensively studied as a relevant drug target. Crystal structures often underestimate NS3‐NS2B flexibility, whereas they can adopt different conformational states depending on the bound substrate. We conducted molecular dynamics simulations (∼30 μs) with a non‐ and covalently bound inhibitor to understand the conformational changes in the DENV‐3 NS3‐NS2B complex. Our results show that the open‐closing movement of the protease exposes multiple druggable subpockets that can be investigated in later drug discovery efforts.